000 01151 a2200349 4500
005 20250514200206.0
264 0 _c20050113
008 200501s 0 0 eng d
022 _a0309-0167
024 7 _a10.1111/j.1365-2559.2004.01903.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLewis, F
245 0 0 _aTesting for HER2 in breast cancer.
_h[electronic resource]
260 _bHistopathology
_cSep 2004
300 _a207-17 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Review
650 0 4 _aBreast Neoplasms
_xdiagnosis
650 0 4 _aFemale
650 0 4 _aGenetic Testing
650 0 4 _aHumans
650 0 4 _aImmunohistochemistry
_xmethods
650 0 4 _aIn Situ Hybridization, Fluorescence
_xmethods
650 0 4 _aReceptor, ErbB-2
_xanalysis
650 0 4 _aReproducibility of Results
650 0 4 _aSensitivity and Specificity
700 1 _aJackson, P
700 1 _aLane, S
700 1 _aCoast, G
700 1 _aHanby, A M
773 0 _tHistopathology
_gvol. 45
_gno. 3
_gp. 207-17
856 4 0 _uhttps://doi.org/10.1111/j.1365-2559.2004.01903.x
_zAvailable from publisher's website
999 _c15028421
_d15028421